D14.3 Benign neoplasm, bronchus and lung - analogs
Description «D14.3 Benign neoplasm, bronchus and lung» | ||||||||
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 20% Compare D37.6 Neoplasm of uncertain or unknown behaviour, liver, gallbladder and bile ducts
- 20% Compare C22 Malignant neoplasm of liver and intrahepatic bile ducts
- 20% Compare C78.7 Secondary malignant neoplasm of liver and intrahepatic bile duct
- 20% Compare C78.0 Secondary malignant neoplasm of lung
- 16% Compare D34 Benign neoplasm of thyroid gland
- 16% Compare D29.2 Benign neoplasm, testis
- 16% Compare D13.0 Benign neoplasm, oesophagus
- 15% Compare C34.1 Malignant neoplasm, upper lobe, bronchus or lung
- 15% Compare D13.4 Benign neoplasm, liver
- 15% Compare C34.9 Malignant neoplasm, bronchus or lung, unspecified
- 15% Compare C22.9 Malignant neoplasm, liver, unspecified
- 15% Compare C22.0 Malignant neoplasm, liver cell carcinoma
- 15% Compare D29.0 Benign neoplasm, penis
- 15% Compare C22.7 Malignant neoplasm, other specified carcinomas of liver
- 15% Compare C30-C39 Malignant neoplasms of the respiratory and thoracic organs
- 15% Compare D31 Benign neoplasm of eye and adnexa
- 15% Compare C18.3 Malignant neoplasm, hepatic flexure
- 10% Compare C40.2 Malignant neoplasm, long bones of lower limb
- 10% Compare D12 Benign neoplasm of colon, rectum, anus and anal canal
- 10% Compare C18.4 Malignant neoplasm, transverse colon
- 10% Compare C93.0 Acute monoblastic/monocytic leukaemia
- 10% Compare C18.6 Malignant neoplasm, descending colon
- 10% Compare C34.3 Malignant neoplasm, lower lobe, bronchus or lung
- 10% Compare C92.4 Acute promyelocytic leukaemia [PML]
- 10% Compare C94 Other leukaemias of specified cell type
- 10% Compare C34.8 Malignant neoplasm, overlapping lesion of bronchus and lung
- 10% Compare D24 Benign neoplasm of breast
- 10% Compare C92.5 Acute myelomonocytic leukaemia
- 10% Compare C41.8 Malignant neoplasm, overlapping lesion of bone and articular cartilage
- 10% Compare C40.0 Malignant neoplasm, scapula and long bones of upper limb
- 10% Compare C94.2 Acute megakaryoblastic leukaemia
- 10% Compare C50.0 Malignant neoplasm, nipple and areola
- 10% Compare D29 Benign neoplasm of male genital organs
- 10% Compare C41.1 Malignant neoplasm, mandible
- 10% Compare C62 Malignant neoplasm of testis
- 10% Compare C18 Malignant neoplasm of colon
- 10% Compare C52 Malignant neoplasm of vagina
- 10% Compare C40.1 Malignant neoplasm, short bones of upper limb
- 10% Compare C34.2 Malignant neoplasm, middle lobe, bronchus or lung
- 10% Compare C40.3 Malignant neoplasm, short bones of lower limb
- 10% Compare C62.1 Malignant neoplasm, descended testis
- 10% Compare C18.2 Malignant neoplasm, ascending colon
- 10% Compare C78.1 Secondary malignant neoplasm of mediastinum
- 10% Compare D16.5 Benign neoplasm, lower jaw bone
- 10% Compare C79.0 Secondary malignant neoplasm of kidney and renal pelvis
- 10% Compare C70.1 Malignant neoplasm, spinal meninges
- 10% Compare D16.8 Benign neoplasm, pelvic bones, sacrum and coccyx
- 10% Compare C76.0 Malignant neoplasm, head, face and neck
- 10% Compare D14.0 Benign neoplasm, middle ear, nasal cavity and accessory sinuses
- 10% Compare C62.9 Malignant neoplasm, testis, unspecified
Learn more about the selection of analogues
- Medical online service designed to help in differential diagnosis.
- Find similar diseases for a diagnosis that causes irritation.
- If you are a professional, then the help of artificial intelligence will help in the express diagnostics.
The advantage of Kiberis is its versatility, thanks to which it is able to select analogues for anything, including for diseases and diagnoses. Artificial intelligence analyzes descriptions of diseases, clinical recommendations for their treatment, real statistics on making diagnoses and displays the most similar diseases with a degree of similarity in percent.